Skip to main content
|

Add a bookmark to get started

Bookmarks info
Victoria Cristofaro

Victoria Cristofaro

Associate, Campos Mello Advogados (cooperation firm)*
São Paulo
About

Victoria is experienced in advice related to the drafting of service agreements and informed consent documents for clinical trials. She focuses on pre-clinical and clinical contracts.

In a recent matter, she assisted a biopharmaceutical company in drafting a clinical services agreement to be executed with the company’s sites, principal investigators and contract research organizations (CROs). She has also assisted the company in drafting an Informed consent document for patients participating in phase III of clinical trials for new drugs.

Victoria is additionally experienced in advising leading providers of healthcare software on the regulatory aspects of their business in Brazil. She counseled on regulation and public policy changes and their impact on the digital health arena, providing recommendations to the clients concerning their processes, methods, telehealth business models and sustainability solutions for the distribution of health-related services through electronic and telecommunication technologies.

DLA Piper and Campos Mello Advogados (CMA) are separate and independent law firms, which work in cooperation with one another. Partners of DLA Piper are not partners of CMA; and CMA partners are not partners of DLA Piper. 

Areas of FocusHealthcareLife SciencesRegulatory and Government AffairsTechnology and Commercial TransactionsTechnology
Bar admissionsBrazil
Languages
  • Portuguese
  • English
  • Spanish
  • French
Education
  • Pontifica Catholic University of São Paulo, B.A., 2021
  • The Hague University of Applied Sciences, Law Exchange

Pro Bono

Victoria has written about pro bono matters, including children’s and adolescents’ rights to health and health information in schools.

Publications

  • Co-Author, "Breaking taboos: the welcome ascension of FemTechs in the healthcare market"
  • Co-Author, "The new regulatory scheme for Software as a Medical Device approved by Anvisa"
  • Co-Author, "The importance behind the recent scientific advances in reversing ageing in human egg cells"
  • Co-Author, "Telehealth in Brazil: the Bill goes to the Senate and the Federal Court of Medicine regulates the practice of telemedicine"
  • Co-Author, "Digital Health Transformation: the new Brazilian law on digital drugs leaflets"
  • Co-Author, "The Federal Council of Nursing regulates the exercise of Telenursing"
  • Co-Author, "The Brazilian Minister of Health approves the Ordinance regulating telehealth in Brazil"
  • Co-Author, "The Brazilian Federal Council of Pharmacy regulates telepharmacy"
  • Co-Author, "Anvisa approves new regulatory agenda until 2023"
  • Co-Author, "Anvisa updates import rules for cannabis-based products"
  • Co-Author, "New rules on pesticides and toxicological reassessment process"

Prior Experience

Victoria represented one of the largest pharmaceutical companies in Brazil in a partnership to conduct a phase II clinical trial of a therapy with the potential to treat generalized anxiety disorders (GAD) and post-traumatic stress disorder (PTSD).

She has also engaged in public policy discussions and advocacy for a CRO before the Brazilian National Health Surveillance Agency (Anvisa) and relevant professional councils in relation to the at-home processing of blood samples.

Among her past matters, Victoria advised on administrative and judicial proceedings brought by a patient with an incurable disease against his health plan which interrupted his treatment during the COVID-19 pandemic.
Victoria regularly speaks and writes about emerging issues in the life sciences, healthcare and cannabis spaces.

In 2017, she participated in the Legal Knowledge Olympics by the Brazilian Civil Law Academy with the assistance of the Brazilian Bar Association, São Paulo.

Memberships And Affiliations

  • Brazilian Bar Association
  • Leadership Alliance for Women 

Connect

Phone

+55 11 3077 3500
(Work, São Paulo (Cooperation Firm))
CallvCardLinkedInPrint
Legal noticesPrivacy policyCookie policyModern slaveryFraud AlertSitemap

DLA Piper is a global law firm operating through various separate and distinct legal entities. For further information about these entities and DLA Piper's structure, please refer to the Legal Notices page of this website. All rights reserved. Attorney advertising.

© 2024 DLA Piper